Provided by Tiger Trade Technology Pte. Ltd.

AKESO

101.900
0.000
Volume:4.87M
Turnover:499.88M
Market Cap:93.85B
PE:-71.09
High:104.500
Open:101.400
Low:101.100
Close:101.900
52wk High:179.000
52wk Low:80.200
Shares:921.00M
HK Float Shares:921.00M
Volume Ratio:0.85
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.433
ROE:-14.53%
ROA:-4.32%
PB:8.92
PE(LYR):-71.09
PS:26.41

Loading ...

Akeso (SEHK:9926) Could Be 41% Undervalued On Phase II Breast Cancer Trial Progress

Simply Wall St.
·
Yesterday

HK Movers | Hong Kong Biotech Stocks Rally; Genscript Bio Jumps Over 7%, Zai Lab Gains Over 6%

Tiger Newspress
·
Yesterday

Movement Alert|AKESO Rises 3.15% in Regular Trading, Bispecific ADC Plus Ivonescimab Completes First Patient Dosing in Breast Cancer Phase II Trial

Market Focus
·
Yesterday

Akeso Doses First Patient in Phase II Trial of Ak146d1 ADC Plus Ivonescimab in Advanced Breast Cancer

Reuters
·
Aug 10

Akeso Advances IO2.0 + Adc2.0 Strategy: First Patient Dosed in Phase Ii Study of Trop2/Nectin-4 Bispecific ADC (Ak146d1) Combined with Ivonescimab in Breast Cancer

THOMSON REUTERS
·
Aug 10

HK Movers | Pharma Stocks Jump With Viva Biotech up 15%, WuXi XDC, WuXi Biologics up 6%

Tiger Newspress
·
Aug 10

Movement Alert|AKESO Rises 4% in Regular Trading, Multiple International Registrational Clinical Studies Advancing Rapidly

Market Focus
·
Aug 10

Biotech ETF Gains Over 5% as Leading Innovators Report Strong Earnings and Global Supply Chain Remains Robust

Stock News
·
Aug 07

Movement Alert|AKESO Rises 3.28% in Regular Trading, Ivonescimab Plus Enfortumab Vedotin Phase II/III Registrational Study Initiated for First-Line UC

Market Focus
·
Aug 07

Movement Alert|AKESO Rises 3.04% in Regular Trading, Innovative Drug Sector Collectively Strengthens Ahead of Major Academic Conferences

Market Focus
·
Aug 05

Akeso (SEHK:9926) Dosed Its First AK138D1 Patient, Is The 47% Undervalued View Too Bullish?

Simply Wall St.
·
Aug 03

China's domestic innovative drugs set for overseas revenue breakthrough as policy support strengthens

Stock News
·
Jul 31

Movement Alert|AKESO Falls 3.29% in Regular Trading, Share Option Exercise Price Inversion Compounds Biotech Sector Weakness

Market Focus
·
Jul 30

China's Biotechnology Success Meets Increasing US Scrutiny, Analytics Firm Says

MT Newswires Live
·
Jul 29

Movement Alert|AKESO Falls 3.04% in Regular Trading, Share Option Grant Sparks Dilution Concerns Amid Biotech Sector Pullback

Market Focus
·
Jul 28

Akeso Doses First Patient in Phase Ib/II NSCLC Trial of HER3 ADC Ak138d1 with Ivonescimab

Reuters
·
Jul 28

Nomura Adjusts Akeso's Price Target to HK$138.29 From HK$142.50, Keeps at Buy

MT Newswires Live
·
Jul 27

AKESO (09926) Grants 3,603,500 Share Options and 1,648,500 Restricted Share Units

Stock News
·
Jul 26

Akeso Grants 3,603,500 Share Options at HK$ 99.5 Exercise Price Under Employee Incentive Plan

Reuters
·
Jul 26

Akeso (SEHK:9926) Partners With MSK, Is The Discount To Fair Value Justified?

Simply Wall St.
·
Jul 24